Prestige Consumer Healthcare PBH Remainder of Fiscal Year 2025

Remainder of Fiscal Year 2025 at other companies

Bausch + LombBLCO

——

Hims & Hers HealthHIMS

——

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$281.6M-5.0%

Gross profit$146.3M-13.9%

Operating income$75.5M-14.6%

Net income$53.9M+7.6%

EPS (diluted)$1.13+11.9%

Balance sheet

See full

Cash & equivalents$63.9M-34.8%

Total debt$1.0B-0.2%

Total equity$1.9B+2.9%

Total assets$3.5B+2.7%

Cash flow

See full

Operating cash flow$42.8M-30.7%

CapEx$5.2M+49.8%

Free cash flow$37.6M-35.5%

Valuation

See full

Market cap$2.18B-34.1%

Enterprise value$3.16B-27.3%

P/E11.5×-4.0×

P/S2×-0.9×

Profitability

See full

Gross margin54.7%-1.1pp

Operating margin28.4%-1.2pp

Net margin17.5%-1.4pp

FCF margin22.6%+1.3pp

Returns & leverage

See full

Return on equity10.2%-2.1pp

Debt / equity0.6×0.0×

Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's remainder of fiscal year 2025.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prestige Consumer Healthcare's remainder of fiscal year 2025?: Prestige Consumer Healthcare (PBH) reported remainder of fiscal year 2025 of $4.27M in Q4 2025.
How has Prestige Consumer Healthcare's remainder of fiscal year 2025 changed year-over-year?: Prestige Consumer Healthcare's remainder of fiscal year 2025 increased by 1.5% year-over-year, from $4.2M to $4.27M.